This study highlights the mechanism underlying the spike‐activated ERK/VEGF pathway and intestinal inflammation, providing potential therapeutic targets for the mitigation of GI symptoms to improve the overall condition of COVID‐19 patients. The gene discussed is VEGFA; the disease is COVID-19.